- Home
- SYBX vs GENK Comparison
SYBX vs GENK Comparison
Compare SYBX & GENK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYBX
- GENK
- Stock Information
- Founded
- SYBX N/A
- GENK 2011
- Country
- SYBX United States
- GENK United States
- Employees
- SYBX N/A
- GENK N/A
- Industry
- SYBX Biotechnology: Pharmaceutical Preparations
- GENK Restaurants
- Sector
- SYBX Health Care
- GENK Consumer Discretionary
- Exchange
- SYBX Nasdaq
- GENK Nasdaq
- Market Cap
- SYBX 16.4M
- GENK 16.3M
- IPO Year
- SYBX N/A
- GENK 2023
- Fundamental
- Price
- SYBX $1.59
- GENK $3.21
- Analyst Decision
- SYBX
- GENK Strong Buy
- Analyst Count
- SYBX 0
- GENK 2
- Target Price
- SYBX N/A
- GENK $7.00
- AVG Volume (30 Days)
- SYBX 19.9K
- GENK 46.3K
- Earning Date
- SYBX 11-11-2025
- GENK 11-11-2025
- Dividend Yield
- SYBX N/A
- GENK 3.77%
- EPS Growth
- SYBX N/A
- GENK N/A
- EPS
- SYBX N/A
- GENK N/A
- Revenue
- SYBX N/A
- GENK $216,137,000.00
- Revenue This Year
- SYBX N/A
- GENK $12.35
- Revenue Next Year
- SYBX N/A
- GENK $14.62
- P/E Ratio
- SYBX N/A
- GENK N/A
- Revenue Growth
- SYBX N/A
- GENK 10.67
- 52 Week Low
- SYBX $0.90
- GENK $3.10
- 52 Week High
- SYBX $1.96
- GENK $10.33
- Technical
- Relative Strength Index (RSI)
- SYBX 64.64
- GENK 42.98
- Support Level
- SYBX $1.45
- GENK $3.11
- Resistance Level
- SYBX $1.54
- GENK $3.39
- Average True Range (ATR)
- SYBX 0.06
- GENK 0.15
- MACD
- SYBX 0.01
- GENK 0.02
- Stochastic Oscillator
- SYBX 94.74
- GENK 32.35
About SYBX Synlogic Inc.
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.
About GENK GEN Restaurant Group Inc.
GEN Restaurant Group Inc operates an Asian casual dining restaurant chain, offering an extensive menu of traditional Korean and Korean-American food, including high-quality meats, poultry, seafood, and mixed vegetables. It operates 43 Gen Korean BBQ restaurants in the United States.